Follow
Pascal Hammel
Pascal Hammel
Unknown affiliation
Verified email at aphp.fr
Title
Cited by
Cited by
Year
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors
E Raymond, L Dahan, JL Raoul, YJ Bang, I Borbath, C Lombard-Bohas, ...
New England Journal of Medicine 364 (6), 501-513, 2011
29152011
FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer
T Conroy, P Hammel, M Hebbar, M Ben Abdelghani, AC Wei, JL Raoul, ...
New England Journal of Medicine 379 (25), 2395-2406, 2018
23792018
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
T Golan, P Hammel, M Reni, E Van Cutsem, T Macarulla, MJ Hall, ...
New England Journal of Medicine 381 (4), 317-327, 2019
18902019
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised …
JP Neoptolemos, DH Palmer, P Ghaneh, EE Psarelli, JW Valle, ...
The Lancet 389 (10073), 1011-1024, 2017
18432017
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial
C Louvet, R Labianca, P Hammel, G Lledo, MG Zampino, T André, ...
Journal of Clinical Oncology 23 (15), 3509-3516, 2005
12532005
Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib …
P Hammel, F Huguet, JL van Laethem, D Goldstein, B Glimelius, P Artru, ...
Jama 315 (17), 1844-1853, 2016
10112016
Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone …
B Chauffert, F Mornex, F Bonnetain, P Rougier, C Mariette, O Bouché, ...
Annals of oncology 19 (9), 1592-1599, 2008
8022008
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
D Goldstein, RH El-Maraghi, P Hammel, V Heinemann, V Kunzmann, ...
Journal of the National Cancer Institute 107 (2), dju413, 2015
6842015
Risk of pancreatic adenocarcinoma in chronic pancreatitis
D Malka, P Hammel, F Maire, P Rufat, I Madeira, F Pessione, P Levy, ...
Gut 51 (6), 849-852, 2002
6342002
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies
F Huguet, T André, P Hammel, P Artru, J Balosso, F Selle, ...
Journal of Clinical Oncology 25 (3), 326-331, 2007
6312007
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct
P Hammel, A Couvelard, D O'Toole, A Ratouis, A Sauvanet, JF Fléjou, ...
New England Journal of Medicine 344 (6), 418-423, 2001
5752001
Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct
B Terris, P Ponsot, F Paye, P Hammel, A Sauvanet, G Molas, P Bernades, ...
The American journal of surgical pathology 24 (10), 1372-1377, 2000
4842000
Value of endoscopic ultrasound guided fine needle aspiration biopsy in the diagnosis of solid pancreatic masses
M Voss, P Hammel, G Molas, L Palazzo, A Dancour, D O'toole, B Terris, ...
Gut 46 (2), 244-249, 2000
4622000
Risk factors for diabetes mellitus in chronic pancreatitis
D Malka, P Hammel, A Sauvanet, P Rufat, D O'Toole, P Bardet, J Belghiti, ...
Gastroenterology 119 (5), 1324-1332, 2000
4562000
Pancreatic involvement in von Hippel–Lindau disease
PR Hammel, V Vilgrain, B Terris, A Penfornis, A Sauvanet, JM Correas, ...
Gastroenterology 119 (4), 1087-1095, 2000
4552000
Assessment of complications of EUS-guided fine-needle aspiration
D O'Toole, L Palazzo, R Arotçarena, A Dancour, A Aubert, P Hammel, ...
Gastrointestinal endoscopy 53 (4), 470-474, 2001
4502001
Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): a randomized phase III study
J Edeline, M Benabdelghani, A Bertaut, J Watelet, P Hammel, JP Joly, ...
Journal of Clinical Oncology 37 (8), 658-667, 2019
4272019
Gemcitabine and oxaliplatin with or without cetuximab in advanced biliary-tract cancer (BINGO): a randomised, open-label, non-comparative phase 2 trial
D Malka, P Cervera, S Foulon, T Trarbach, C de la Fouchardière, ...
The lancet oncology 15 (8), 819-828, 2014
4122014
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE …
HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ...
The Lancet Oncology 18 (9), 1159-1171, 2017
3662017
The natural history of hereditary pancreatitis: a national series
V Rebours, MC Boutron-Ruault, M Schnee, C Férec, C Le Maréchal, ...
Gut 58 (1), 97-103, 2009
3632009
The system can't perform the operation now. Try again later.
Articles 1–20